시장보고서

상품코드

2075304

무좀 시장 : 질환 유형별, 치료 유형별, 투여 경로별, 유통 채널별, 지역별

Global Athletes Foot Market, By Disease Type, By Treatment Type, By Route of Administration, By Distribution Channel, By Geography

발행일: 2026년 04월 | 리서치사: 구분자

Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

가격

Unprintable PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,500

￦ 6,704,000

PDF & Excel (Multi User License - Up to 7 Users)

PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

US $ 7,000

￦ 10,428,000

PDF & Excel (Corporate User License)

PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000

￦ 14,898,000

※ 부가세 별도

한글목차

영문목차

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 무좀 시장은 2026년에 14억 8,000만 달러 규모가 될 것으로 추정되며, 2033년까지 21억 2,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 5.2%로 성장할 것으로 전망됩니다.

보고서 범위		보고서 상세
기준 연도:	2025년	2026년 시장 규모:	14억 8,000만 달러
과거 데이터 기간:	2020-2024년	예측 기간:	2026-2033년
2026년부터 2033년까지 예측 기간의 CAGR:	5.20%	2033년 시장 규모 예측:	21억 2,000만 달러

무좀(발 백선)은 발 피부, 특히 발가락 사이에서 발생하는 흔한 진균 감염증이지만, 발톱이나 손으로도 퍼질 가능성이 있습니다. '무좀'이라는 명칭은 스포츠 선수들에게서 흔히 나타나는 데서 유래했습니다. 이는 곰팡이가 운동선수들에게 흔히 나타나는 땀으로 젖은 신발 안과 같이 따뜻하고 습한 환경에서 번식하기 쉽기 때문입니다. 이 질환은 발가락 사이나 발바닥에 가려움증, 따끔거림, 화끈거림이 나타나는 것이 특징입니다. 또한, 환부의 피부가 붉어지거나, 벗겨지거나, 갈라지거나, 물집이 생길 수도 있습니다. 불쾌한 증상이 동반되기도 하지만, 일반적으로는 경미하며 일반의약품으로 치료할 수 있습니다. 증상이 오래 지속되거나 중증인 경우에는 처방약을 통한 치료가 필요할 수도 있습니다. 무좀은 피부의 죽은 바깥층에서 번식하는 곰팡이의 일종인 피부사상균에 의해 발생합니다. 이 곰팡이는 오염된 표면과의 직접적인 접촉이나 수건, 신발, 의류를 통한 간접적인 접촉을 통해 쉽게 퍼집니다. 공용 샤워실, 수영장, 라커룸은 감염의 온상이 되기 때문에 운동선수나 헬스장 이용자들은 특히 감염되기 쉬운 경향이 있습니다. 무좀 예방을 위해서는 발의 위생 관리가 매우 중요합니다. 여기에는 발을 깨끗하고 건조한 상태로 유지하는 것, 통기성이 좋은 신발을 신는 것, 정기적으로 양말을 갈아 신는 것, 그리고 곰팡이가 있을 가능성이 있는 공공장소에서 맨발로 걷지 않는 것이 포함됩니다. 무좀에 걸린 분은 감염이 신체의 다른 부위나 다른 사람에게 퍼지지 않도록 주의해야 합니다. 무좀의 조기 발견과 조기 치료는 감염이 통제하기 어려워지거나 더 심각한 이차 세균 감염을 일으키는 것을 방지하기 위해 중요합니다. 원인, 예방법, 치료법을 이해함으로써 이 증상에 효과적으로 대처하고 발의 건강을 유지할 수 있습니다.

시장 역학:

전 세계 무좀 시장은 주로 고령 인구 증가, 비만율 상승, 그리고 수영 등 물가에서의 활동 참여 확대에 따른 감염률 상승에 힘입어 성장하고 있습니다. 또한, 치료받지 않은 발 곰팡이 감염이 미치는 영향에 대한 건강에 대한 인식이 높아지면서 자가 진단이나 일반의약품 사용이 늘어나고 있습니다. 그러나 시판(OTC) 외용 크림이나 파우더를 이용한 가정 요법 등의 대체 치료법은 처방약의 수익 창출 가능성을 저해할 수 있습니다.

본 조사의 주요 특징:

본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
또한, 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공하고 있습니다.
본 조사에서는 다음의 주요 항목(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)을 바탕으로 전 세계 무좀 시장 내 주요 기업 개요을 소개하고 있습니다.
본 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
세계 무좀 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
이해관계자들은 전 세계 무좀 시장을 분석하는 데 사용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.

Report Coverage	Report Details
Base Year:	2025	Market Size in 2026:	USD 1.48 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.20%	2033 Value Projection:	USD 2.12 Bn

Athlete's foot, also known as tinea pedis, is a common fungal infection that affects the skin on the feet, particularly the spaces between the toes, but can also spread to the toenails and hands. It is named athlete's foot because it is frequently seen in athletes, as the fungus thrives in warm, moist environments, such as the inside of sweaty shoes, which are common among sports participants. This condition is characterized by itching, stinging, and burning sensations between the toes or on the soles of the feet. The affected skin may also become red, flaky, cracked, or blistered. Although the condition can be uncomfortable, it is generally mild and can be treated with over-the-counter antifungal medications. In persistent or severe cases, prescription-strength treatments may be necessary. Athlete's foot is caused by dermatophytes, a type of fungus that grows on the dead outer layer of skin. The fungus spreads easily through direct contact with contaminated surfaces or through indirect contact with towels, shoes, or clothing. Communal showers, swimming pools, and locker rooms are hotspots for transmission, making athletes and gym-goers particularly susceptible. Good foot hygiene plays a crucial role in preventing athlete's foot. This includes keeping the feet clean and dry, wearing breathable footwear, changing socks regularly, and avoiding walking barefoot in public places where the fungus may be present. Individuals with athlete's foot should also be careful not to spread the infection to other parts of their body or to other people. Early detection and treatment of athlete's foot are important to prevent the infection from becoming more difficult to manage or leading to more serious secondary bacterial infections. Understanding the causes, prevention, and treatment options enables individuals to effectively deal with this condition and maintain good foot health.

Market Dynamics:

The global athlete's foot market is primarily driven by the rising prevalence of the infection due to a growing geriatric population, increasing obesity rates, and greater participation in aquatic activities. Growing health awareness regarding implications of untreated fungal infections of feet is also supporting self-diagnosis and over-the-counter medication. However, alternative treatment options such as home remedies using over-the-counter (OTC) topical creams and powders may hinder revenue generation potential for prescription drugs.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global athlete's foot market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Perrigo Company Plc., Novartis AG, Valeant Pharmaceuticals International, GlaxoSmithKline plc, Bayer AG, Teva Pharmaceuticals Industries Ltd., Mylan NV, Glenmark Pharmaceutical Ltd, Taro Pharmaceutical Industries Ltd., Camber Pharmaceuticals Inc, Aurobindo Pharma Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global athlete's foot market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global athlete's foot market

Detailed Segmentation:

Global Athlete's Foot Market, By Drug Class
Antifungals
Combination
Global Athlete's Foot Market, By Disease Indication
Interdigital
Plantar
Vesicular
Global Athlete's Foot Market, By Route of Administration
Topical
Oral
Global Athlete's Foot Market, By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Top Companies in Global Athlete's Foot Market:
Perrigo Company Plc.
Novartis AG
Valeant Pharmaceuticals International
GlaxoSmithKline plc
Bayer AG
Teva Pharmaceuticals Industries Ltd.
Mylan NV
Glenmark Pharmaceutical Ltd
Taro Pharmaceutical Industries Ltd.
Camber Pharmaceuticals Inc
Aurobindo Pharma Ltd

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Athlete€(TM)s Foot, By Drug Class
- Market Athlete€(TM)s Foot, By Disease Indication
- Market Athlete€(TM)s Foot, By Route of Administration
- Market Athlete€(TM)s Foot, By Distribution Channel
- Market Athlete€(TM)s Foot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
  - Growing health and hygiene awareness
  - Increasing spending on personal care and sports healthcare
  - Technological advancements in treatment options
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER€(TM)s Analysis
Mergers, Acquisitions, and Collaborations
Supply Side and Demand Side Analysis
Economic Impact

5. Global Athlete€(TM)s Foot Market, By Drug Class, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Antifungals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Combination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Global Athlete€(TM)s Foot Market, By Disease Indication, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Interdigital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Plantar
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Vesicular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

7. Global Athlete€(TM)s Foot Market, By Route of Administration, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Segment Trends
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

8. Global Athlete€(TM)s Foot Market, By Distribution Channel, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

9. Global Athlete€(TM)s Foot Market, By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2021 €"2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Company Profile
- Perrigo Company Plc.
  - Drug Class Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Novartis AG
  - Drug Class Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Valeant Pharmaceuticals International
  - Drug Class Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- GlaxoSmithKline plc
  - Company Highlights
  - Drug Class Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Bayer AG
  - Company Highlights
  - Drug Class Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Teva Pharmaceuticals Industries Ltd.
  - Company Highlights
  - Drug Class Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Mylan NV
  - Company Highlights
  - Drug Class Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Glenmark Pharmaceutical Ltd
  - Company Highlights
  - Drug Class Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Taro Pharmaceutical Industries Ltd.
  - Company Highlights
  - Drug Class Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Camber Pharmaceuticals Inc
  - Company Highlights
  - Drug Class Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Aurobindo Pharma Ltd
  - Company Highlights
  - Drug Class Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
Analyst Views

11. Section

References
Research Methodology
About us

무좀 시장 : 질환 유형별, 치료 유형별, 투여 경로별, 유통 채널별, 지역별